7651 - 7700 of 8571 Results
Title
Year
- Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI2022RESTRICTEDTitle: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSIJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288Citation Count: 8
-
RESTRICTEDTitle: Progressive Supranuclear Palsy Syndrome Associated With a Novel TauopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page: 1094End Page: 1098Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485Citation Count: 10
- Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis2022RESTRICTEDTitle: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85Citation Count: 0
- Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant2022OPENTitle: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S VariantJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9484727Citation Count: 8
- The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis2022OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 2
-
OPENTitle: Physical activity and exercise for people with Parkinson’sJournal Name: Advances in Clinical Neuroscience & RehabilitationPublisher: Whitehouse PublishingVol: 21Issue #: 2Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.47795/fenh4822Best OA location URL: https://acnr.co.uk/download/22608/Citation Count: 1
-
OPENTitle: Using former carers’ expertise in peer support for carers of people with Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00381-0Best OA location URL: https://www.nature.com/articles/s41531-022-00381-0.pdfCitation Count: 7
-
OPENTitle: Fecal microbiome alterations in treatment-naive de novo Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00395-8Best OA location URL: https://www.nature.com/articles/s41531-022-00395-8.pdfCitation Count: 20
- Motor cortex excitability is reduced during freezing of upper limb movement in Parkinson’s disease2022OPENTitle: Motor cortex excitability is reduced during freezing of upper limb movement in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00420-wBest OA location URL: https://www.nature.com/articles/s41531-022-00420-w.pdfCitation Count: 6
-
OPENTitle: The silver linings of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00283-1Best OA location URL: https://www.nature.com/articles/s41531-022-00283-1.pdfCitation Count: 5
- Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes2022OPENTitle: Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00373-0Best OA location URL: https://www.nature.com/articles/s41531-022-00373-0.pdfCitation Count: 14
- Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neurons2022OPENTitle: Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00355-2Best OA location URL: https://www.nature.com/articles/s41531-022-00355-2.pdfCitation Count: 41
- Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients2022OPENTitle: Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00366-zBest OA location URL: https://www.nature.com/articles/s41531-022-00366-z.pdfCitation Count: 37
-
OPENTitle: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00400-0Best OA location URL: https://www.nature.com/articles/s41531-022-00400-0.pdfCitation Count: 15
- Evolution patterns of probable REM sleep behavior disorder predicts Parkinson’s disease progression2022OPENTitle: Evolution patterns of probable REM sleep behavior disorder predicts Parkinson’s disease progressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00303-0Best OA location URL: https://www.nature.com/articles/s41531-022-00303-0.pdfCitation Count: 7
-
OPENTitle: Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00409-5Best OA location URL: https://www.nature.com/articles/s41531-022-00409-5.pdfCitation Count: 32
- Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease2022OPENTitle: Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-15874-4Best OA location URL: https://www.nature.com/articles/s41598-022-15874-4.pdfCitation Count: 79
-
OPENTitle: Large-scale societal dynamics are reflected in human mood and brainJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-08569-3Best OA location URL: https://www.nature.com/articles/s41598-022-08569-3.pdfCitation Count: 5
- Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal Study2022OPENTitle: Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal StudyJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 810End Page: 817Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01455-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01455-8.pdfCitation Count: 7
-
OPENTitle: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-07706-2Best OA location URL: https://www.nature.com/articles/s41598-022-07706-2.pdfCitation Count: 13
-
OPENTitle: Leveraging Patient Preference Information in Medical Device Clinical Trial DesignJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 57Issue #: 1Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s43441-022-00450-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s43441-022-00450-9.pdfCitation Count: 7
- Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?2022RESTRICTEDTitle: Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?Journal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 1039End Page: 1044Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-022-01477-2Citation Count: 3
- Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variants2022OPENTitle: Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variantsJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41398-022-01913-1Best OA location URL: https://www.nature.com/articles/s41398-022-01913-1.pdfCitation Count: 17
- Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor function2022OPENTitle: Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor functionJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00607-8Best OA location URL: https://www.nature.com/articles/s41746-022-00607-8.pdfCitation Count: 63
- Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease2022OPENTitle: Identifying and characterising sources of variability in digital outcome measures in Parkinson’s diseaseJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00643-4Best OA location URL: https://www.nature.com/articles/s41746-022-00643-4.pdfCitation Count: 20
- Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks2022OPENTitle: Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networksJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00674-xBest OA location URL: https://www.nature.com/articles/s41746-022-00674-x.pdfCitation Count: 26
- Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel2022OPENTitle: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert PanelJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 4Start Page: 1571End Page: 1582Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00388-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00388-y.pdfCitation Count: 7
- Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses2022OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 1
- Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 7Start Page: 4193End Page: 4201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-05952-wCitation Count: 20
- Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s disease2022RESTRICTEDTitle: Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson’s diseaseJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4745End Page: 4752Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06110-yCitation Count: 7
- The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunction2022RESTRICTEDTitle: The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunctionJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4777End Page: 4784Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06081-0Citation Count: 6
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 5
- Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries2022OPENTitle: Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 CountriesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 303End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00313-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00313-9.pdfCitation Count: 11
- Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment2022OPENTitle: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1319End Page: 1340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00375-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00375-3.pdfCitation Count: 23
- Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial2022OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 7
-
OPENTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 14
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 11
- The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England2022OPENTitle: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in EnglandJournal Name: PharmacoEconomicsPublisher: Springer Science and Business Media LLCVol: 40Issue #: 5Start Page: 559End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40273-022-01132-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40273-022-01132-y.pdfCitation Count: 10
- Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networks2022OPENTitle: Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networksJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-25454-1Best OA location URL: https://www.nature.com/articles/s41598-022-25454-1.pdfCitation Count: 5
-
OPENTitle: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stressJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-20261-0Best OA location URL: https://www.nature.com/articles/s41598-022-20261-0.pdfCitation Count: 20
- Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Pharmacological ReportsPublisher: Springer Science and Business Media LLCVol: 74Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43440-022-00378-9Citation Count: 5
- Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson’s disease2022OPENTitle: Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-09506-0Best OA location URL: https://www.nature.com/articles/s41598-022-09506-0.pdfCitation Count: 5
-
OPENTitle: Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubulesJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 12Start Page: 1196End Page: 1207Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41594-022-00863-yBest OA location URL: https://www.nature.com/articles/s41594-022-00863-y.pdfCitation Count: 46
- Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables2022OPENTitle: Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variablesJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4803End Page: 4809Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06061-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06061-4.pdfCitation Count: 21
- Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker2022RESTRICTEDTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 38
- Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation System2022RESTRICTEDTitle: Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation SystemJournal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 47Issue #: 10Start Page: 3192End Page: 3201Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11064-022-03673-2Citation Count: 4
- Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making Important2022OPENTitle: Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making ImportantJournal Name: NeuroethicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12152-022-09496-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12152-022-09496-w.pdfCitation Count: 3
- Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRI2022OPENTitle: Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRIJournal Name: NeuroinformaticsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 4Start Page: 879End Page: 896Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12021-022-09565-8Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2021/09/20/2021.09.18.460908.full.pdfCitation Count: 5
- Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome2022OPENTitle: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndromeJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 6Start Page: 3677End Page: 3682Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-05919-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-05919-x.pdfCitation Count: 5
-
OPENTitle: Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive statusJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 9Start Page: 5251End Page: 5258Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06129-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06129-1.pdfCitation Count: 1